Werbung
Karyopharm Therapeutics Aktie Analyse
| 05.07.19 | Karyopharm Therapeutics Buy | H.C. Wainwright & Co. | |
| 03.12.18 | Karyopharm Therapeutics Buy | B. Riley FBR | |
| 09.11.18 | Karyopharm Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
| 15.11.17 | Karyopharm Therapeutics Buy | H.C. Wainwright & Co. | |
| 15.09.17 | Karyopharm Therapeutics Outperform | RBC Capital Markets | |
| 08.09.16 | Karyopharm Therapeutics Buy | H.C. Wainwright & Co. | |
| 28.06.16 | Karyopharm Therapeutics Outperform | Robert W. Baird & Co. Incorporated | |
| 16.03.16 | Karyopharm Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
|
Werbung
|
|||
| 22.12.15 | Karyopharm Therapeutics Buy | Canaccord Adams | |
| 12.08.15 | Karyopharm Therapeutics Buy | MLV Capital | |
| 10.11.14 | Karyopharm Therapeutics Outperform | Oppenheimer & Co. Inc. | |
| 05.11.14 | Karyopharm Therapeutics Buy | MLV Capital | |
Werbung
Werbung